TY - JOUR
T1 - 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
T2 - Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
AU - Otto, Catherine M.
AU - Nishimura, Rick A.
AU - Bonow, Robert O.
AU - Carabello, Blase A.
AU - rwin, John P.
AU - Gentile, Federico
AU - Jneid, Hani
AU - Krieger, ric V.
AU - Mack, Michael
AU - McLeod, Christopher
AU - O'Gara, Patrick T.
AU - Rigolin, Vera H.
AU - Sundt, Thoralf M.
AU - Thompson, Annemarie
AU - Toly, Christopher
N1 - Publisher Copyright:
© 2021 Lippincott Williams and Wilkins. All rights reserved.
PY - 2021/2/2
Y1 - 2021/2/2
N2 - Aim: This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. Methods: A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, Cochrane, Agency for Healthcare Research and Quality Reports, and other selected database relevant to this guideline. Structure: Many recommendations from the earlier valvular heart disease guidelines have been updated with new evidence and provides newer options for diagnosis and treatment of valvular heart disease. This summary includes only the recommendations from the full guideline which focus on diagnostic work-up, the timing and choice of surgical and catheter interventions, and recommendations for medical therapy. The reader is referred to the full guideline for graphical flow charts, text, and tables with additional details about the rationale for and implementation of each recommendation, and the evidence tables detailing the data considered in developing these guidelines.
AB - Aim: This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. Methods: A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, Cochrane, Agency for Healthcare Research and Quality Reports, and other selected database relevant to this guideline. Structure: Many recommendations from the earlier valvular heart disease guidelines have been updated with new evidence and provides newer options for diagnosis and treatment of valvular heart disease. This summary includes only the recommendations from the full guideline which focus on diagnostic work-up, the timing and choice of surgical and catheter interventions, and recommendations for medical therapy. The reader is referred to the full guideline for graphical flow charts, text, and tables with additional details about the rationale for and implementation of each recommendation, and the evidence tables detailing the data considered in developing these guidelines.
KW - AHA Scientific Statements
KW - anscatheter aortic valve replacement or implantation
KW - anticoagulation therapy
KW - aortic regurgitation
KW - aortic stenosis
KW - bicuspid aortic valve
KW - cardiac surgery
KW - infective endocarditis
KW - mitral regurgitation
KW - mitral stenosis
KW - mitral transcatheter edge-to-edge repair
KW - prosthetic valve
KW - pulmonic regurgitation
KW - pulmonic stenosis
KW - tricuspid regurgitation
KW - tricuspid stenosis
KW - valvular heart disease
UR - http://www.scopus.com/inward/record.url?scp=85102090489&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102090489&partnerID=8YFLogxK
U2 - 10.1161/CIR.0000000000000932
DO - 10.1161/CIR.0000000000000932
M3 - Review article
C2 - 33332149
AN - SCOPUS:85102090489
SN - 0009-7322
VL - 143
SP - E35-E71
JO - Circulation
JF - Circulation
IS - 5
ER -